If its a CE yes then a CR is on the cards I think. Genuine uptake of this therapy will only occur after significant clinical studies a la SRX. As for VLI coverage agree with the comments here, paid 'research' to get the punters excited running up to CE mark. Good luck in your exit strategies.
Useless Valuation Van Leeuwenhoeck Institute initiates Research Coverage, page-16
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
-0.005(0.43%) |
Mkt cap ! $16.42M | |||
| Open | High | Low | Value | Volume |
| $1.19 | $1.20 | $1.15 | $26.30K | 22.63K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 881 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.18 | 7619 | 2 |
View Market Depth
| Last trade - 13.43pm 30/06/2025 (20 minute delay) ? |
| OSL (ASX) Chart |